This website uses cookies
Read our Privacy policy and Terms of use for more information.
You are now part of a community studying longevity biotechnology before the field becomes mainstream. Use this page to understand the research process, see the strongest examples, and tell us which areas matter most to you.
Start with the permanent record of companies on the Tracker, Scout list and Watchlist. Look for the date each company entered, its framework score, publicly supportable valuation information and material progress since entry.
Open the Company TrackerSee how EverLife evaluates an ambitious engineering approach that could eventually address several failing organ systems together. Look for the difference between a compelling mechanism, evidence in living systems and what still must be demonstrated in people.
Read the Organ Systems ReviewThis review shows why a company can be promising enough for the Scout list while still requiring decisive human evidence. Look for how mechanism, market opportunity, valuation and the next clinical milestone fit together.
Read the Antimicrobial ReviewSee how EverLife compares many companies working on the same underlying biology instead of evaluating one headline in isolation. Look for the evidence and investability gates that separate an interesting technology from a company that deserves closer attention.
Read the Mitochondrial ReviewWhich areas would you most like EverLife to investigate next? Reply to any newsletter or email Eric directly with one or more priorities: cardiovascular health, skin health, immune aging, organ replacement, brain health, muscle preservation, cancer-related aging biology, or lifespan preservation. You can also suggest a company or mechanism.
Submit a Research InterestIndependent, impersonal educational research. Not investment or medical advice.